StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
9
Publishing Date
2022 - 05 - 24
9
Sector
Finance
1
Health technology
6
Manufacturing
1
Tags
Acquisition
1
Air
1
Application
1
Approval
4
Approved
1
Breast cancer
1
California
1
Cancer
1
Contract
1
Europe
1
Fda
5
Fda-approvals
4
Hemescreen
1
Keytruda
1
License
1
Living
1
Market
1
N/a
2
Offering
1
Order
1
Pharmaceutical
1
Plague
1
Platform
1
Psoriasis
1
Regulatory
1
Risk
1
Tapinarof
1
Technosphere
1
Therapeutics
1
Therapy
1
Treatment
1
Vtama
1
Entities
Amphastar pharmaceuticals, inc.
1
Haymaker acquisition corp. ii
1
Mannkind corporation
1
Merck & company, inc.
1
Precipio, inc.
1
Roivant sciences ltd.
1
Singlepoint inc.
1
Uniqure n.v.
1
United therapeutics corporation
2
Symbols
AMPH
1
HYAC
1
MNKD
1
MRK
1
PRPO
1
QURE
1
ROIV
1
SING
1
UTHR
2
Exchanges
Nasdaq
8
Nyse
1
Crawled Date
2024 - 02 - 12
12
2023 - 12 - 22
15
2023 - 12 - 21
12
2023 - 12 - 12
11
2023 - 12 - 08
9
2023 - 10 - 16
9
2023 - 10 - 12
11
2023 - 10 - 05
9
2023 - 10 - 02
11
2023 - 09 - 27
9
2023 - 09 - 25
12
2023 - 09 - 21
10
2023 - 07 - 24
9
2023 - 06 - 30
16
2023 - 06 - 21
10
2023 - 06 - 20
14
2023 - 06 - 06
9
2023 - 06 - 05
10
2023 - 05 - 30
11
2023 - 05 - 11
9
2023 - 05 - 03
10
2023 - 05 - 01
12
2023 - 04 - 27
11
2023 - 04 - 17
12
2023 - 03 - 21
10
2023 - 03 - 16
10
2023 - 03 - 15
11
2023 - 02 - 09
9
2023 - 01 - 31
11
2023 - 01 - 30
9
2022 - 12 - 20
11
2022 - 12 - 16
11
2022 - 12 - 13
9
2022 - 06 - 21
9
2022 - 05 - 24
9
2022 - 05 - 03
12
2022 - 04 - 06
9
2022 - 03 - 28
10
2022 - 03 - 16
9
2022 - 03 - 01
10
2022 - 02 - 23
9
2022 - 01 - 31
11
2022 - 01 - 19
9
2022 - 01 - 13
9
2021 - 12 - 16
9
2021 - 12 - 15
12
2021 - 12 - 09
9
2021 - 12 - 01
10
2021 - 09 - 29
9
2021 - 07 - 29
9
2021 - 06 - 29
9
2021 - 06 - 25
10
2021 - 06 - 11
20
2021 - 06 - 10
10
2021 - 05 - 28
13
2021 - 05 - 21
10
2021 - 05 - 04
11
2020 - 12 - 21
10
2020 - 12 - 17
11
2020 - 12 - 03
9
Crawled Time
11:00
4
12:00
1
13:20
1
15:20
2
22:00
1
Source
singlepoint.com
1
www.biospace.com
7
www.globenewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
approved
crawled date :
2022 - 05 - 24
save search
Haymaker Acquisition Corp. III Announces Stockholder Approval of Business Combination with Biote
Published:
2022-05-24
(Crawled : 22:00)
- globenewswire.com
HYAC
4
|
$10.47
39K
|
Finance
|
4.07%
|
O:
0.79%
H:
2.46%
C:
-2.17%
acquisition
approval
uniQure Announces FDA Acceptance of Biologics License Application for Etranacogene Dezaparvovec under Priority ReviewIf approved, etranacogene dezaparvovec would be the first gene therapy option for people living with hemophilia B
Published:
2022-05-24
(Crawled : 15:20)
- biospace.com/
QURE
|
$4.665
-0.75%
190K
|
Health Technology
|
-64.82%
|
O:
-1.35%
H:
8.88%
C:
7.74%
fda
application
license
therapy
living
Precipio Receives CE-IVD Certification to Market Multiple HemeScreen® Panels in EuropeThis Regulatory Approval Opens the Company’s Reach to the European Market
Published:
2022-05-24
(Crawled : 15:20)
- biospace.com/
PRPO
|
$6.73
460
|
Health Technology
|
529.49%
|
O:
-0.93%
H:
13.2%
C:
1.88%
hemescreen
approval
market
BOX Pure Air Has Received First Initial Orders as an Approved Supplier for Multimillion Dollar Contract Offering in California to Address Indoor Air Quality in Non-Public Schools
Published:
2022-05-24
(Crawled : 13:20)
- singlepoint.com
SING
|
$0.2001
-1.91%
72K
|
|
103.8%
|
O:
0.0%
H:
8.89%
C:
3.4%
offering
air
california
approved
contract
order
European Commission Approves KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Adjuvant Monotherapy After Surgery for Locally Advanced or Early-Stage Triple-Negative Breast Cancer at High Risk of Recurrence
Published:
2022-05-24
(Crawled : 12:00)
- biospace.com/
MRK
|
$125.08
0.02%
1.8M
|
Health Technology
|
33.75%
|
O:
0.8%
H:
0.58%
C:
0.41%
keytruda
risk
cancer
breast cancer
MannKind’s Technosphere® Inhalation Platform Utilized in FDA-Approved Tyvaso DPI™
Published:
2022-05-24
(Crawled : 11:00)
- biospace.com/
UTHR
|
$236.05
1.84%
140K
|
Health Technology
|
21.41%
|
O:
10.26%
H:
4.52%
C:
4.01%
MNKD
|
$4.055
0.12%
460K
|
Health Technology
|
8.58%
|
O:
12.33%
H:
5.25%
C:
-4.53%
technosphere
platform
fda
FDA Approves Dermavant’s VTAMA® (tapinarof) cream, 1% for the Treatment of Plaque Psoriasis in Adults: First Topical Novel Chemical Entity Launched for Psoriasis in the U.S. in 25 Years
Published:
2022-05-24
(Crawled : 11:00)
- biospace.com/
ROIV
|
$10.58
-1.21%
1.2M
|
Manufacturing
|
193.42%
|
O:
5.21%
H:
4.82%
C:
1.82%
vtama
treatment
fda
psoriasis
tapinarof
plague
United Therapeutics Announces FDA Approval of Tyvaso DPI™
Published:
2022-05-24
(Crawled : 11:00)
- biospace.com/
UTHR
|
$236.05
1.84%
140K
|
Health Technology
|
21.41%
|
O:
10.26%
H:
4.52%
C:
4.01%
fda
approval
therapeutics
Amphastar Receives FDA Approval for Regadenoson
Published:
2022-05-24
(Crawled : 11:00)
- biospace.com/
AMPH
|
$40.36
-1.32%
180K
|
Health Technology
|
18.17%
|
O:
-0.98%
H:
1.84%
C:
-0.96%
fda
approval
Gainers vs Losers
64%
36%
Top 10 Gainers
INVO
|
$2.78
265.79%
200M
|
Health Technology
RYDE
|
$4.66
70.7%
410K
|
n/a
EDBL
|
$7.4
62.64%
12M
|
GRTX
|
$0.237
39.41%
13M
|
Health Technology
VNDA
|
$5.28
30.37%
21M
|
Health Technology
VIRX
|
$0.912
27.59%
170K
|
Manufacturing
WISA
4
|
$7.72
26.56%
51M
|
Electronic Technology
TCON
|
$2.135
24.85%
440K
|
Health Technology
AGFY
|
$0.37
24.2%
28M
|
BCAN
|
$1.085
23.73%
7.4M
|
Construction
Your saved searches
Save your searches and get alerts when important news are released.